This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Martin Chandler - Innovator in Recombinant Insulin Production
Introduction
Martin Chandler is a notable inventor based in Palo Alto, California. He has made significant contributions to the field of biotechnology, particularly in the production of recombinant insulin. His innovative approach has led to advancements in the purification processes used in insulin manufacturing.
Latest Patents
Chandler holds a patent for a process for preparing recombinant insulin using microfiltration. This patent describes the use of two tandem microfiltration steps in a single downstream purification unit operation. These steps effectively reduce both soluble and insoluble impurities while exchanging the insulin product into a suitable buffer for downstream purification.
Career Highlights
Martin Chandler is currently employed at Merck Sharp & Dohme Corporation, a leading global healthcare company. His work at Merck has allowed him to focus on improving biopharmaceutical processes, contributing to the efficiency and effectiveness of insulin production.
Collaborations
Chandler has collaborated with several professionals in his field, including Sean S. Gant and Michael J. Iammarino. These collaborations have fostered a productive environment for innovation and development in biotechnological applications.
Conclusion
Martin Chandler's contributions to the field of recombinant insulin production exemplify the impact of innovative thinking in biotechnology. His work continues to influence the industry and improve healthcare outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile